Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation
Two-armed Single Blinded Non-inferiority Registry Based Randomized Control Trial Comparing Transfascial Sutures for Mesh Fixation to No Mesh Fixation for Open Retromuscular Repairs
1 other identifier
interventional
325
1 country
1
Brief Summary
This will be a single blinded, registry based, non-inferiority, randomized control trial comparing transfacial sutures for mesh fixation to no mesh fixation in open retromuscular repairs. The primary outcome of interest is recurrence measured one year postoperatively as per standard of care at Cleveland Clinic Center for Abdominal Core Health. Hence, recurrence will be measured using either physical examination, CT scan, or the Ventral Hernia Recurrence Inventory (VHRI). Study population will include all adult patients (18 years or older) undergoing elective open ventral hernia repair of a clean (Wound class I) defect, where the midline fascia can be approximated and mesh will be placed in the retromuscular position. Only a midline approach to hernia repair and hernia widths equal to or less than 20cm measured intraoperatively will be included
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedStudy Start
First participant enrolled
October 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2022
CompletedJune 22, 2023
June 1, 2023
3.2 years
May 1, 2019
June 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence
primary outcome of interest is recurrence measured one year postoperatively as per standard of care at the Cleveland Clinic Center for Abdominal Core Health. Hence, recurrence will be measured using either physical examination, CT scan, or the Ventral Hernia Recurrence Inventory (VHRI), either during a physical or a virtual clinic visit and/or using the telephone. The VHRI is a validated patient reported outcomes tool, a three-question survey that can be administered directly to patients without clinical interaction.
One year
Secondary Outcomes (4)
Post-operative pain
Baseline and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.
Post-operative pain
Baseline, first 7 days post-operatively, and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.
Daily opioid requirements
first 7 days of the post-operative period
Length of stay
From date of admission to hospital until the date of discharge from hospital, assessed up to 60 weeks
Study Arms (2)
Transfascial sutures for mesh fixation
OTHERMesh will be placed in the retromuscular space, with wide overlap on all sides. Full thickness transfascial sutures will be placed circumferentially to secure the mesh using slowly absorbable no. 1 sutures. A total of at least six transfascial sutures will be placed universally for all patients with additional sutures allowed according to each surgeon's discretion. Additional bone or ligament sutures for mesh fixation will be allowed according to each surgeon's discretion.
No mesh fixation
NO INTERVENTIONMesh will be placed in the retromuscular space, with wide overlap on all sides. No fixation method will be used. Bone or ligament sutures for mesh fixation will not be allowed.
Interventions
Sutures that pass through the full thickness of the abdominal wall, which are used routinely for mesh fixation
Eligibility Criteria
You may qualify if:
- Undergoing elective open ventral hernia repair, where the midline fascia can be approximated and mesh will be placed in the retromuscular position
- A midline approach to hernia repair
- Hernia widths equal to or less than 20cm measured intraoperatively
You may not qualify if:
- Patients unable to give consent and vulnerable populations.
- Parastomal hernias
- Hernia width measuring more than 20cm intraoperatively
- Patients planned for minimally invasive approaches or open repairs with mesh placed in a position other than retromuscular, or those who were not able to undergo successful retromuscular mesh placement.
- Open repairs performed through a different incision than the standard midline approach
- Inability to close the midline fascia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Center for Abdominal Core Health
Cleveland, Ohio, 44195, United States
Related Publications (1)
Ellis RC, Petro CC, Krpata DM, Beffa LRA, Miller BT, Montelione KC, Maskal SM, Tu C, Huang LC, Lau B, Fafaj A, Rosenblatt S, Rosen MJ, Prabhu AS. Transfascial Fixation vs No Fixation for Open Retromuscular Ventral Hernia Repairs: A Randomized Clinical Trial. JAMA Surg. 2023 Aug 1;158(8):789-795. doi: 10.1001/jamasurg.2023.1786.
PMID: 37342018DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ajita S Prabhu
The Cleveland Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Surgery
Study Record Dates
First Submitted
May 1, 2019
First Posted
May 6, 2019
Study Start
October 21, 2019
Primary Completion
December 18, 2022
Study Completion
December 18, 2022
Last Updated
June 22, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared, rather the results of the aggregate groups of patients will be shared